Salem Investment Counselors’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328 Hold
275
﹤0.01% 1202
2026
Q1
$465 Buy
+275
New +$566 ﹤0.01% 1171
2025
Q4
Sell
-275
Closed -$801 992
2025
Q3
$801 Hold
275
﹤0.01% 1135
2025
Q2
$498 Hold
275
﹤0.01% 1118
2025
Q1
$413 Hold
275
﹤0.01% 1152
2024
Q4
$649 Hold
275
﹤0.01% 1112
2024
Q3
$8.09K Hold
275
﹤0.01% 862
2024
Q2
$3.4K Hold
275
﹤0.01% 972
2024
Q1
$5.58K Hold
275
﹤0.01% 910
2023
Q4
$6.19K Hold
275
﹤0.01% 878
2023
Q3
$4.58K Hold
275
﹤0.01% 903
2023
Q2
$6.74K Hold
275
﹤0.01% 887
2023
Q1
$6.63K Hold
275
﹤0.01% 879
2022
Q4
$8.12K Hold
275
﹤0.01% 816
2022
Q3
$12K Buy
+275
New +$7.43K ﹤0.01% 723

Other funds holding FLNA

Salem Investment Counselors's FLNA Position: Q2 2026 in Review

Salem Investment Counselors held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 275 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #1202.

Salem Investment Counselors first reported a position in FLNA in Q3 2022 and has held it in 15 quarters since. The position peaked at $12K in Q3 2022. 20 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Salem Investment Counselors held 275 shares of Filana Therapeutics worth $328 as of Q2 2026.
  • Salem Investment Counselors left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1202 holding.
  • Salem Investment Counselors first reported a position in Filana Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Salem Investment Counselors's Filana Therapeutics position peaked at $12K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.